Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 517-528

  Huibregtse, Inge L ^a   Snoeck, Veerle ^b,c   de Creus, An ^b,c   Braat, Henri ^a   de Jong, Ester C ^a   van Deventer, Sander J H ^a   Rottiers, Pieter ^b,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; OVALBUMIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PROBIOTIC AGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DNA MODIFICATION; DRUG MECHANISM; FEMALE; GENETIC ANALYSIS; IMMUNOLOGICAL TOLERANCE; LACTOCOCCUS LACTIS; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYTOLOGY; DOSE RESPONSE; EVALUATION; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; PEYER PATCH; REGULATORY T LYMPHOCYTE; SPLEEN; TRANSGENIC MOUSE; TRANSPLANTATION;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINES; LACTOCOCCUS LACTIS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PEYER'S PATCHES; PROBIOTICS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 34547503872     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.04.073     Document Type: Article

References (52)

1. Abreu-Martin M.T., and Targan S.R. Regulation of immune responses of the intestinal mucosa. Crit Rev Immunol 16 (1996) 277-309
2. Faria A.M., and Weiner H.L. Oral tolerance. Immunol Rev 206 (2005) 232-259
3. Kraus T.A., and Mayer L. Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol 21 (2005) 692-696
4. Weiner H.L. Current issues in the treatment of human diseases by mucosal tolerance. Ann N Y Acad Sci 1029 (2004) 211-224
5. Friedman A., and Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A 91 (1994) 6688-6692
6. Mowat A.M., Strobel S., Drummond H.E., and Ferguson A. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 45 (1982) 105-113
7. Yoshida T., Hachimura S., and Kaminogawa S. The oral administration of low-dose antigen induces activation followed by tolerization, while high-dose antigen induces tolerance without activation. Clin Immunol Immunopathol 82 (1997) 207-215
8. Sun J., Alison S.M., Thompson K.L., and Fisher V.H. Cell cycle block in anergic T cells during tolerance induction. Cell Immunol 225 (2003) 33-41
9. Huibregtse I.L., van Lent A.U., and van Deventer S.J. Immunopathogenesis of IBD: insufficient suppressor function in the gut?. Gut 56 (2007) 584-592
10. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., Fiers W., and Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000) 1352-1355
11. Vandenbroucke K., Hans W., Van Huysse J., Neirynck S., Demetter P., Remaut E., Rottiers P., and Steidler L. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127 (2004) 502-513
12. Steidler L., Neirynck S., Huyghebaert N., Snoeck V., Vermeire A., Goddeeris B., Cox E., Remon J.P., and Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21 (2003) 785-789
13. Braat H., Rottiers P., Hommes D.W., Huyghebaert N., Remaut E., Remon J.P., van Deventer S.J., Neirynck S., Peppelenbosch M.P., and Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4 (2006) 754-759
14. Gasson M.J. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154 (1983) 1-9
15. McReynolds L., O'Malley B.W., Nisbet A.D., Fothergill J.E., Givol D., Fields S., Robertson M., and Brownlee G.G. Sequence of chicken ovalbumin mRNA. Nature 273 (1978) 723-728
16. van Asseldonk M., Rutten G., Oteman M., Siezen R.J., de Vos W.M., and Simons G. Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95 (1990) 155-160
17. Waterfield N.R., Le Page R.W., Wilson P.W., and Wells J.M. The isolation of lactococcal promoters and their use in investigating bacterial luciferase synthesis in Lactococcus lactis. Gene 165 (1995) 9-15
18. Tobagus I.T., Thomas W.R., and Holt P.G. Adjuvant costimulation during secondary antigen challenge directs qualitative aspects of oral tolerance induction, particularly during the neonatal period. J Immunol 172 (2004) 2274-2285
19. Morelli A.E., Zahorchak A.F., Larregina A.T., Colvin B.L., Logar A.J., Takayama T., Falo L.D., and Thomson A.W. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 98 (2001) 1512-1523
20. Hauet-Broere F., Unger W.W., Garssen J., Hoijer M.A., Kraal G., and Samsom J.N. Functional CD25- and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48h after oral antigen application. Eur J Immunol 33 (2003) 2801-2810
21. Unger W.W., Hauet-Broere F., Jansen W., van Berkel L.A., Kraal G., and Samsom J.N. Early events in peripheral regulatory T-cell induction via the nasal mucosa. J Immunol 171 (2003) 4592-4603
22. Drouault S., Corthier G., Ehrlich S.D., and Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 65 (1999) 4881-4886
23. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., and Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2 (2001) 361-367
24. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., and Reinecker H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
25. Niess J.H., and Reinecker H.C. Dendritic cells: the commanders-in-chief of mucosal immune defenses. Curr Opin Gastroenterol 22 (2006) 354-360
26. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3 (2003) 984-993
27. Kelsall B.L., and Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 206 (2005) 132-148
28. Read S., and Powrie F. CD4(+) regulatory T cells. Curr Opin Immunol 13 (2001) 644-649
29. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
30. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711 119:952-959
31. Frossard C.P., Steidler L., and Eigenmann P.A. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol (2007)
32. Daniel C., Repa A., Wild C., Pollak A., Pot B., Breiteneder H., Wiedermann U., and Mercenier A. Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 61 (2006) 812-819
33. del-Patient K., Ah-Leung S., Creminon C., Nouaille S., Chatel J.M., Langella P., and Wal J.M. Oral administration of recombinant Lactococcus lactis expressing bovine β-lactoglobulin partially prevents mice from sensitization. Clin Exp Allergy 35 (2005) 539-546
34. Repa A., Grangette C., Daniel C., Hochreiter R., Hoffmann-Sommergruber K., Thalhamer J., Kraft D., Breiteneder H., Mercenier A., and Wiedermann U. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22 (2003) 87-95
35. Lider O., Santos L.M., Lee C.S., Higgins P.J., and Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142 (1989) 748-752
36. Zhang X., Izikson L., Liu L., and Weiner H.L. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 167 (2001) 4245-4253
37. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237-1240
38. Faria A.M., and Weiner H.L. Oral tolerance and TGF-β-producing cells. Inflamm Allergy Drug Targets 5 (2006) 179-190
39. Miller A., Lider O., Roberts A.B., Sporn M.B., and Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sci U S A 89 (1992) 421-425
40. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 194 (2001) 629-644
41. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H., and Strober W. TGF-β 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172 (2004) 834-842
42. Chung Y., Lee S.H., Kim D.H., and Kang C.Y. Complementary role of CD4+CD25+ regulatory T cells and TGF-β in oral tolerance. J Leukoc Biol 77 (2005) 906-913
43. Carrier Y., Yuan J., Kuchroo V.K., and Weiner H.L. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-β T-cell-transgenic mice. J Immunol 178 (2007) 179-185
44. Ochi H., Abraham M., Ishikawa H., Frenkel D., Yang K., Basso A.S., Wu H., Chen M.L., Gandhi R., Miller A., Maron R., and Weiner H.L. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+. Nat Med 12 (2006) 627-635
45. Oida T., Zhang X., Goto M., Hachimura S., Totsuka M., Kaminogawa S., and Weiner H.L. CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J Immunol 170 (2003) 2516-2522
46. Coombes J.L., Robinson N.J., Maloy K.J., Uhlig H.H., and Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev 204 (2005) 184-194
47. Fuss I.J., Boirivant M., Lacy B., and Strober W. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 168 (2002) 900-908
48. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T., and Strober W. Transforming growth factor (TGF)-β1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis. J Exp Med 198 (2003) 1179-1188
49. Carrier Y., Yuan J., Kuchroo V.K., and Weiner H.L. Th3 cells in peripheral tolerance. II. TGF-β-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J Immunol 178 (2007) 172-178
50. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+. J Exp Med 198 (2003) 1875-1886
51. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., and Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 (2004) 1455-1465
52. Tang Q., and Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212 (2006) 217-237